Glucovance is indicated as second-line therapy when diet, exercise, and initial treatment with a sulphonylurea or metformin do not result in adequate glycaemic control in patients with type 2 diabetes.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
